Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

10 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (8)
Early P 1 (1)
P 1 (1)
P 3 (3)
P 4 (7)

Trial Status

Recruiting10
Not Yet Recruiting5
Completed3
Unknown2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07643792Phase 4Not Yet Recruiting

Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery

NCT06547255Phase 4CompletedPrimary

Exparel Versus Bupivacaine in Post-operative Pain Control

NCT07271979Not ApplicableCompletedPrimary

Liposomal Bupivacaine Versus Ropivacaine for Preperitoneal Infiltration Analgesia in Upper Abdominal Laparotomy

NCT07432711Not ApplicableRecruiting

The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery

NCT07196631Phase 4Completed

Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

NCT07665762Phase 3Not Yet Recruiting

Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in Patients With Risk Factors for Severe Acute Postoperative Pain

NCT07512635Phase 4Recruiting

Effect of Intercostal Nerve Block With Liposomal Bupivacaine on Quality of Recovery in VATS Partial Pneumonectomy

NCT07641647Phase 4Not Yet Recruiting

The Effect of Bupivacaine Liposomes on Postoperative Pain in Lung Transplant Patients After Intercostal Nerve Block: a Randomized Controlled Study

NCT07577934Not ApplicableRecruiting

Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block

NCT07509866Not ApplicableRecruiting

Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal Block Combined With IPACK Block in Total Knee Arthroplasty

NCT07458256Not ApplicableRecruiting

The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery

NCT07458295Not ApplicableRecruiting

The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology

NCT07458282Not ApplicableRecruiting

The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery

NCT07441902Not ApplicableRecruiting

The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery

NCT07289178Phase 1Not Yet Recruiting

Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy

NCT07245290Early Phase 1Not Yet RecruitingPrimary

Effect of Local Infiltration of Liposomal Bupivacaine on Postoperative Analgesia in Patients With Craniotomy Microvascular Decompression

NCT06740214Phase 3Recruiting

Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty

NCT06145165Phase 4UnknownPrimary

A Analgesic Study of Adductor Canal &IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty

NCT06430112Phase 3Recruiting

Liposomal Bupivacaine vs Ropivacaine for TAPBs

NCT04751344Phase 4UnknownPrimary

Liposomal Bupivacaine Versus Bupivacaine Plain for Operative Pain Management of Forefoot Surgery

Showing all 20 trials

Research Network

Activity Timeline